Mølby L, Rasmussen K, Jensen M K, Pedersen K O
Aalborg Sygehus, medicinsk haematologisk afdeling og klinisk kemisk afdeling.
Ugeskr Laeger. 1992 Feb 3;154(6):323-5.
Development of cobalamin deficiency in the tissues is considered to be a process which lasts for years. Macrocytic anaemia and/or neurological symptoms do not occur until late in this process. Serum cobalamins as the only parameter have proved less suitable for differentiation between healthy individuals with low serum cobalamin values and patients who require cobalamin for the remainder of their lives. The need for a better indicator for cobalamin deficiency has been emphasized. Recently developed methods of measurement have rendered determinations of serum methylmalonic acid possible. This value is raised in cases of cobalamin deficiency in the tissues. The serum methylmalonic values have proved both sensitive and specific to determine the extent to which genuine cobalamin deficiency is present or not and may also be employed for monitoring the effect of treatment as the raised values becomes normalized following substitution therapy with vitamin B12.
组织中钴胺素缺乏的发展被认为是一个持续数年的过程。巨幼细胞贫血和/或神经症状直到这个过程后期才会出现。血清钴胺素作为唯一参数,已被证明不太适合区分血清钴胺素值低的健康个体和余生需要钴胺素的患者。人们强调需要一个更好的钴胺素缺乏指标。最近开发的测量方法使血清甲基丙二酸的测定成为可能。在组织钴胺素缺乏的情况下,这个值会升高。血清甲基丙二酸值已被证明在确定真正的钴胺素缺乏是否存在方面既敏感又特异,并且还可用于监测治疗效果,因为在用维生素B12替代治疗后,升高的值会恢复正常。